Fjarde Ap Fonden Novavax Inc Transaction History

Fjarde Ap Fonden

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$36.28 - $75.29 $838,068 - $1.74 Million	-23,100 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $142,240 - $216,464	-800 Reduced 3.35%	23,100 $4.79 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $2.89 Million - $6.16 Million	23,900 New	23,900 $5.07 Million

291

93.3M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $573M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Fjarde Ap Fonden , based on Form 13F filings with the SEC.

Stay updated on Fjarde Ap Fonden with notifications on news.